NCT06606457Completed
PACE CF, a 3-session Mind-body Pain Management Program for Adults With Cystic Fibrosis
Pilot of PACE CF, a 3-session Mind-body Pain Management Program for Adults With CF
Source: ClinicalTrials.gov · Last updated 12 Dec 2025
Brief summary (registry, in English)
Many people living with cystic fibrosis (CF) experience pain. However, pain is sometimes unrecognized and under-managed in people with CF. Both medication and non-medication interventions can be used to treat pain and ideally, there is a multicomponent management approach. The goal of this study is to pilot a new 3-session non-medication mind-body pain management intervention specifically designed for adults with cystic fibrosis (CF). The intervention is titled Pain Acknowledgement Coping and Empowerment in CF (PACE CF). PACE CF will be administered by a member of the CF care team via telehealth visits to participants at home or during a hospitalization. The aim of the study is to evaluate the feasibility and patient acceptability of the intervention as well as preliminary evidence of the impact of the intervention on pain and its interference in daily life. The study will also examine outcomes such as perceived coping, quality of life, symptoms of depression or anxiety, and use of prescribed pain medication, in an exploratory manner.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 10 Sept 2024
- Start date
- 10 Sept 2024
- Primary completion date
- 9 Apr 2025
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Cystic fibrosis
- NCT number
- NCT06606457
What you commit to
- Study type: Interventional
- Participants enrolled: 20
- From 10 Sept 2024 to the primary completion date, 9 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- CF severity or lung/liver transplant status, if they are otherwise able to participate in CBT;
- Participation in concomitant pain treatments (e.g., pain medications), as ideally, patients will engage in multi-component pain interventions;
- psychosocial treatments (with the exception of another formal CBT for pain) or psychopharmacologic treatments at baseline. All concomitant psychosocial and pain-directed treatments will be tracked and considered in analysis.
Other
- Presenting an acute safety risk to self or others at baseline. Participants will not be excluded for the following reasons:
Who the study is looking for
- diagnosis of CF;
- age \> 18 years;
- report of pain affecting them at least moderately (score ≥ 2) on the IPOS item;
- pain lasting at least one month;
- English-speaking;
- participant willing and able to give informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Massachusetts General Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.